“…pregnancies (%) [34,50] can disturb endocrine profiles causing an aberrant follicular, oviductal or uterine environment and disruptions in oocyte maturation, embryo development, or implantation [78][79][80]. Safety also can be an issue with eCG and hCG as these are large, foreign glycoproteins that persist for days in circulation and can induce gonadotropin-neutralizing antibodies after subsequent eCG/hCG treatments [74,81,82]. Too frequent administration results in refractoriness, which can be avoided by giving eCG or hCG treatments no more than once every 6-12 mo [81,82].…”